Previous 10 | Next 10 |
CALGARY, Alberta, April 23, 2020 (GLOBE NEWSWIRE) -- TransGlobe Energy Corporation (“TransGlobe” or the “Company”) (AIM & TSX: “TGL” & NASDAQ: “TGA”) was notified on April 20, 2020 by the Listing Qualifications Department of Th...
LONDON, April 23, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that it will report its audited financial results for the three months ended Ma...
Jadestone Energy Announces Further Capex Reductions, Australia Infill Wells Deferred SINGAPORE / ACCESSWIRE / April 22, 2020 / Jadestone Energy Inc. (AIM:JSE) ("Jadestone" or the "Company"), an independent oil and gas production company focused on the Asia Pacific region, notes the collap...
Achieves record average quarterly production of 9,688 bopd in Q1 2020 Prudent management of cash resources and dividend suspension Calgary, Alberta and Houston, Texas--(Newsfile Corp. - April 21, 2020) - PetroTal Corp. (TSXV: TAL) (AIM: PTAL) (" PetroTal " or the " Company ") is p...
LONDON, April 20, 2020 (GLOBE NEWSWIRE) -- Horizonte Minerals Plc , (AIM: HZM, TSX: HZM) ('Horizonte' or 'the Company') the nickel development company focused in Brazil, announces that its annual report and accounts for the year ended 31 December 2019, together with Management’...
OCALA, FL / ACCESSWIRE / April 20, 2020 / AIM ImmunoTech Inc. (NYSE American:AIM), an immuno-pharma company focused on the research and development of therapeutics to treat immune disorders, viral diseases and multiple types of cancers, today announced that Chief Executive Officer, Thomas K....
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION. THIS IS AN ANNOUNCEMENT UNDER RULE 2.4 OF THE CITY CODE ON TAKE...
DIDCOT, UK / ACCESSWIRE / April 17, 2020 / Altus Strategies Plc (AIM:ALS & TSX-V:ALTS), the Africa focused project and royalty generator, at the request of IIROC, hereby clarifies certain disclosure in its news release entitled "Preliminary Economic Assessment Commences at Diba Gold Proj...
PARSORTIX PERFORMANCE DEMONSTRATED IN HEAD AND NECK CANCER Molecular analysis demonstrates measurement of key cancer genes and methylation status from a simple blood test Direct comparison highlights key advantages of Parsortix compared to antibody-based approach GUILDFORD, S...
LONDON, April 16, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for respiratory diseases, announces that all resolutions proposed...
News, Short Squeeze, Breakout and More Instantly...
OCALA, Fla., July 24, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced the publication of new pre-clinical data concerning the company’s drug Ampligen as part of a combinational therapy in the...
OCALA, Fla., June 10, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced that Thomas K. Equels, MS JD, Chief Executive Officer of AIM will participate in the Virtual Investor Pitch Con...
OCALA, Fla., June 03, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced that Thomas K. Equels, MS JD, Chief Executive Officer of AIM will participate in the Virtual Investor Lunch Break Series ...